Company

Starget Pharma Ltd.

Starget Pharma develops radiopharmaceutical compounds for solid tumors.

About

Starget Pharma's pipeline includes compounds intended to deliver radioisotopes to malignant tumor tissue for imaging or treatment. Founded in 2019, the company is based in Ramat Hasharon, Israel. It raised USD 18 million in Series A funding in February 2026.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in